emocha uses video technology and human engagement to empower patients to take every dose of medication as prescribed. emocha facilitates a daily touchpoint for patients in order to expand access to treatment, extend the reach of existing care teams, and retain patients in care. emocha’s turnkey, enterprise adherence solution operates through dose-by-dose observation and clinical assessment of potential administration problems, including technique and side effects. Coupled with daily engagement, support, and incentives, emocha is the first holistic solution to medication non-adherence.
emocha was established in 2014 after our founders licensed a mobile health software created by Johns Hopkins University clinician-scientists. The software that powers emocha’s platform was one of the first mobile health technologies ever developed and was originally used to assist healthcare workers treating patients in Uganda with HIV. Since then, we have expanded to become a turnkey service to improve medication adherence for patients around the globe for a number of infectious and chronic conditions. emocha is used in public health departments, clinical trials, health systems, and managed care organizations to achieve high medication adherence rates and engage patients in care.
Total Funding: $15 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 51 to 100
Founded: 2014
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Emocha
Systems Administrator
Baltimore, Maryland
Sr. UX Designer
Baltimore, Maryland
Sr. Mobile Engineer
Baltimore, Maryland
Sr. Full Stack Web Developer
Baltimore, Maryland
Senior Sales Lead, Health Plans & Provider
Baltimore, Maryland